• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.基于方酸的基质金属蛋白酶-1肽类抑制剂
J Org Chem. 2005 Dec 23;70(26):10792-802. doi: 10.1021/jo0517848.
2
Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.以环丙烷衍生的肽模拟物作为P1'和P2'取代基的基质金属蛋白酶抑制剂的设计、合成与评价
J Org Chem. 2002 Jun 14;67(12):4062-75. doi: 10.1021/jo0110698.
3
The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.基质金属蛋白酶8-巴比妥酸盐抑制剂复合物的1.8埃晶体结构揭示了一种以前未观察到的胶原酶底物识别机制。
J Biol Chem. 2001 May 18;276(20):17405-12. doi: 10.1074/jbc.M007475200. Epub 2001 Jan 22.
4
Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.脑啡肽降解二肽基氨基肽酶:活性位点的表征与选择性抑制
Mol Pharmacol. 1986 Oct;30(4):338-44.
5
X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.一种与基质溶解素复合的新型基质金属蛋白酶抑制剂的X射线结构。
Protein Sci. 2001 May;10(5):923-6. doi: 10.1110/ps.48401.
6
Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.异羟肟酸酯抑制剂对膜型1基质金属蛋白酶的抑制作用:亚位点口袋的研究。
J Med Chem. 1998 Apr 9;41(8):1209-17. doi: 10.1021/jm970404a.
7
Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.具有 P2' 谷氨酸的简单拟二肽:基质金属蛋白酶和其他金属蛋白酶的新型抑制剂家族。
J Biol Chem. 2012 Aug 3;287(32):26647-56. doi: 10.1074/jbc.M112.380782. Epub 2012 Jun 11.
8
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.新型巯基硫化物抑制剂对膜型1基质金属蛋白酶的酶活性及细胞介导的底物裂解的抑制作用。
Biochem J. 2005 Dec 15;392(Pt 3):527-36. doi: 10.1042/BJ20050545.
9
Role of sulfonamide group in matrix metalloproteinase inhibitors.磺胺基团在基质金属蛋白酶抑制剂中的作用。
Curr Med Chem. 2008;15(4):368-73. doi: 10.2174/092986708783497300.
10
Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approach.
Bioorg Med Chem. 2005 Jul 15;13(14):4527-43. doi: 10.1016/j.bmc.2005.04.051.

引用本文的文献

1
Synthesis and evaluation of squaramide and thiosquaramide inhibitors of the DNA repair enzyme SNM1A.DNA修复酶SNM1A的方酰胺和硫代方酰胺抑制剂的合成与评价
Bioorg Med Chem. 2021 Sep 15;46:116369. doi: 10.1016/j.bmc.2021.116369. Epub 2021 Aug 25.
2
Examining the Impact of Squaric Acid as a Crosslinking Agent on the Properties of Chitosan-Based Films.研究丁烯二酸作为交联剂对壳聚糖基薄膜性能的影响。
Int J Mol Sci. 2021 Mar 24;22(7):3329. doi: 10.3390/ijms22073329.
3
A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A.一种含羟肟酸的核苷抑制 DNA 修复核酸内切酶 SNM1A。
Org Biomol Chem. 2019 Sep 21;17(35):8094-8105. doi: 10.1039/c9ob01133a. Epub 2019 Aug 5.
4
Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.基质金属蛋白酶抑制剂作为血管疾病发病机制及治疗研究的工具
Exp Suppl. 2012;103:209-79. doi: 10.1007/978-3-0348-0364-9_7.
5
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.基于吡咯酮的金属蛋白酶 2 和 3 的抑制剂可能作为构象选择性抑制剂发挥作用。
Chem Biol Drug Des. 2011 Aug;78(2):191-8. doi: 10.1111/j.1747-0285.2011.01148.x. Epub 2011 Jun 20.
6
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.将受体柔性和诱导契合效应纳入 MMP-2 抑制剂的设计中。
J Mol Recognit. 2010 Mar-Apr;23(2):173-82. doi: 10.1002/jmr.989.

本文引用的文献

1
Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.氨甲酰膦酸基质金属蛋白酶抑制剂3:环戊基氨甲酰膦酸在实验性转移和血管生成中的体内评估
Clin Cancer Res. 2005 May 15;11(10):3925-9. doi: 10.1158/1078-0432.CCR-04-1985.
2
New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.基质金属蛋白酶抑制剂的新开端:高亲和力锌结合基团的鉴定
J Am Chem Soc. 2004 Jul 14;126(27):8388-9. doi: 10.1021/ja0485513.
3
Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).两种新型N-甲基-D-天冬氨酸拮抗剂的特性:EAA-090(2-[8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1(7)-烯-2-基]乙基膦酸)和EAB-318(R-α-氨基-5-氯-1-(膦酰基甲基)-1H-苯并咪唑-2-丙酸盐酸盐)。
J Pharmacol Exp Ther. 2004 Aug;310(2):563-70. doi: 10.1124/jpet.104.066092. Epub 2004 Apr 9.
4
Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases.方酸:一种设计蛋白酪氨酸磷酸酶抑制剂的新基序。
Org Lett. 2004 Jan 8;6(1):83-6. doi: 10.1021/ol036121w.
5
Squaric acid N-hydroxylamides: synthesis, structure, and properties of vinylogous hydroxamic acid analogues.方酸N-羟基酰胺:乙烯型异羟肟酸类似物的合成、结构及性质
J Org Chem. 2003 Nov 28;68(24):9233-41. doi: 10.1021/jo035175g.
6
Regulation of matrix metalloproteinases: an overview.基质金属蛋白酶的调控:概述
Mol Cell Biochem. 2003 Nov;253(1-2):269-85. doi: 10.1023/a:1026028303196.
7
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonists.4,4-二取代-2-咪唑啉酮的不对称合成:强效NK1拮抗剂
Org Lett. 2003 Nov 13;5(23):4249-51. doi: 10.1021/ol030104p.
8
Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.基质金属蛋白酶:其结构及在急性冠状动脉综合征中作用的综述
Cardiovasc Res. 2003 Oct 1;59(4):812-23. doi: 10.1016/s0008-6363(03)00516-9.
9
Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.5-取代的2-双芳基硫代环戊烷羧酸作为特异性基质金属蛋白酶抑制剂的立体定向合成
J Med Chem. 2003 Aug 28;46(18):3840-52. doi: 10.1021/jm0307638.
10
Synthesis and paralytic activities of squaryl amino acid-containing polyamine toxins.含角鲨烯氨基酸的多胺毒素的合成与麻痹活性
Amino Acids. 2003 Apr;24(3):293-301. doi: 10.1007/s00726-002-0402-9.

基于方酸的基质金属蛋白酶-1肽类抑制剂

Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.

作者信息

Onaran M Burak, Comeau Anthony B, Seto Christopher T

机构信息

Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.

出版信息

J Org Chem. 2005 Dec 23;70(26):10792-802. doi: 10.1021/jo0517848.

DOI:10.1021/jo0517848
PMID:16356002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527039/
Abstract

[structure: see text] A series of squaric acid-peptide conjugates were synthesized and evaluated as inhibitors of MMP-1. The cyclobut-3-enedione core was substituted at the 3-position with several functional groups, such as -N(alkyl)OH, -NHOH, and -OH, that are designed to bind to the zinc atom in the active site of the metalloprotease. The 4-position of the cyclobut-3-enedione was derivatized with mono- or dipeptides that are designed to bind in the S1' and S2' subsites of the enzyme, and position the metal chelating group appropriately in the active site for binding to zinc. Positional scanning revealed that -N(Me)OH provided the highest level of inhibition among the chelating groups that were tested, and Leu-Tle-NHMe was the preferred amino acid sequence. A combination of these groups yielded an inhibitor with an IC50 value of 95 microM. For one inhibitor, conversion of one of the carbonyl groups on the cyclobut-3-enedione core to a thiocarbonyl group resulted in a 18-fold increase in potency, and yielded a compound with an IC50 value of 15 microM.

摘要

[结构:见正文] 合成了一系列方酸 - 肽缀合物,并评估其作为基质金属蛋白酶 -1(MMP -1)抑制剂的活性。环丁 -3- 烯二酮核心在 3 位被几个官能团取代,如 -N(烷基)OH、-NHOH 和 -OH,这些官能团旨在与金属蛋白酶活性位点中的锌原子结合。环丁 -3- 烯二酮的 4 位用单肽或二肽进行衍生化,这些肽旨在结合在酶的 S1' 和 S2' 亚位点,并将金属螯合基团适当地定位在活性位点以与锌结合。位置扫描显示,在测试的螯合基团中,-N(Me)OH 提供了最高水平的抑制作用,且 Leu - Tle - NHMe 是优选的氨基酸序列。这些基团的组合产生了一种 IC50 值为 95 μM 的抑制剂。对于一种抑制剂,将环丁 -3- 烯二酮核心上的一个羰基转化为硫羰基导致活性提高了 18 倍,并产生了一种 IC50 值为 15 μM 的化合物。